CTRN vs JAZZ · rev $753.1M vs P/E 1988, rev $4.07B
Citi Trends Inc (CTRN) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Citi Trends Inc (CTRN) is a apparel retail company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported CTRN revenue for 2025-02-01 was $753.1M. Net income was -$43.2M. Revenue was up 0.7% from 2024-02-03 to 2025-02-01. CTRN currently screens at market cap $258.4M.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
CTRN currently screens at market cap $258.4M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the CTRN and JAZZ stock pages for the full models.
Not investment advice.